Martin Auster, Chief Financial Officer at Ventyx Biosciences, Inc. (VTYX), sold 56,000 shares at $38.76 ($2.1M) on 2023-04-25, disclosed to the SEC on 2023-04-27.
Open-market sale of $2.1M VTYX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.55 | 18,748 | $704K | 33.1% |
| 2 | $37.55 | 18,748 | $704K | 33.1% |
| 3 | $38.76 | 4,262 | $165K | 7.8% |
| 4 | $38.76 | 4,262 | $165K | 7.8% |
| 5 | $39.23 | 4,990 | $196K | 9.2% |
| 6 | $39.23 | 4,990 |
| $196K |
| 9.2% |
| Total | $38.03 avg | 56,000 | $2.1M | 100% |
| Filing → |
| VTYX | SELL | 2023-07-26 | $995K | — | Filing → |
| VTYX | SELL | 2023-06-07 | $1.9M | — | Filing → |
| VTYX | SELL | 2023-04-19 | $231K | — | Filing → |